Evidence map›Paper›PMID 25374899›Full record

ArticleAmerican journal of clinical and experimental urology2013

Prostate-associated gene 4 (PAGE4) protects cells against stress by elevating p21 and suppressing reactive oxygen species production.

Yu Zeng, Dong Gao, John J Kim, Takumi Shiraishi, Naoki Terada, Yoshiyuki Kakehi, Chuize Kong, Robert H Getzenberg, Prakash Kulkarni

Abstract read
In one paragraph

Article in American journal of clinical and experimental urology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Oxidative stress in prostate hyperplasia and carcinogenesis.Journal of experimental & clinical cancer research : CR · 2016
    Review
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yu ZengDepartment of Urology, The James Buchanan Brady Urological Institute, The Johns Hopkins University School of Medicine Baltimore, Maryland ; Department of Urology, Institute of Urology, The First Hospital, China Medical University Shenyang, China.
Dong GaoDepartment of Urology, The James Buchanan Brady Urological Institute, The Johns Hopkins University School of Medicine Baltimore, Maryland.
John J KimDepartment of Urology, The James Buchanan Brady Urological Institute, The Johns Hopkins University School of Medicine Baltimore, Maryland ; Current address: University of California, Berkeley and University of California, San Francisco Graduate Program in Bioengineering USA.
Takumi ShiraishiDepartment of Urology, The James Buchanan Brady Urological Institute, The Johns Hopkins University School of Medicine Baltimore, Maryland.
Naoki TeradaDepartment of Urology, The James Buchanan Brady Urological Institute, The Johns Hopkins University School of Medicine Baltimore, Maryland.
Yoshiyuki KakehiDepartment of Urology, Kagawa University Faculty of Medicine Kita-gun, Kagawa, Japan.
Chuize KongDepartment of Urology, Institute of Urology, The First Hospital, China Medical University Shenyang, China.
Robert H GetzenbergDepartment of Urology, The James Buchanan Brady Urological Institute, The Johns Hopkins University School of Medicine Baltimore, Maryland.
Prakash KulkarniDepartment of Urology, The James Buchanan Brady Urological Institute, The Johns Hopkins University School of Medicine Baltimore, Maryland ; Department of Oncology, The Johns Hopkins University School of Medicine Baltimore, Maryland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIt is now widely recognized that there is a strong correlation between oxidative stress and the risk of benign and malignant diseases of the prostate. Prostate-associated gene 4 (PAGE4) is a Cancer/Testis Antigen (CTA) that was previously shown to be up-regulated in prostate cancer (PCa) and symptomatic as opposed to histologic benign prostatic hyperplasia (BPH). However, its functional role in these diseases is not fully understood.

methodsThe mRNA level of PAGE4 was detected in isolated cell types in PCa tissues that were obtained from 8 men with PCa. PAGE4 protein expression profile was analyzed in a prostate disease tissue microarray. PAGE4 was overexpressed by pCMV-PAGE4-GFP transfection and cell viability was determined using the WST-1 assay.

resultsPAGE4 expression is highly dynamic; while its expression is very high in fetal prostate it is drastically decreased in the normal adult prostate but is up-regulated both in symptomatic BPH and PCa. However, in the diseased prostate, PAGE4 is highly expressed in the epithelial cells of Proliferative Inflammatory Atrophy (PIA) lesions alluding to a potential stress response function of PAGE4. Consistent with such a role, PAGE4 protein levels are up-regulated when prostate cancer (PCa) cell lines are treated with various stress factors including the proinflammatory cytokine TNFα. Interestingly, in cells challenged with stress there is increased translocation of the PAGE4 protein to the mitochondrion and production of reactive oxygen species is suppressed . Furthermore, p21 is elevated in a p53-independent manner in PAGE4-overexpressing cells which results in impeded cell cycle progression, attenuated stress-induced DNA damage, and decreased cell death.

conclusionsPAGE4 may be contributing to the development of PCa by playing a stress-protective and anti-apoptotic role.

Indexed as

Cancer/Testis AntigenPAGE4proliferative infl ammatory atrophyprostate cancerstress-response

Identifiers

PMID25374899
PMCPMC4219281

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.